US Patent

US8163725 — Gel compositions and methods of use

Formulation · Assigned to Galderma Research and Development SNC · Expires 2031-06-13 · 5y remaining

Vulnerability score 53/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects improved topical gel compositions containing carbomer and methylparaben for treating skin disorders.

USPTO Abstract

Improved topical gel compositions for the treatment of skin disorders are described. The gel compositions contain carbomer and methylparaben, and are substantially free of methylparaben crystalline particles after an extended period of storage.

Drugs covered by this patent

Alphagan (BRIMONIDINE TARTRATE) · Senju Pharmaceutical Co., Ltd

Patent Metadata

Patent number: US8163725
Jurisdiction: US
Classification: Formulation
Expires: 2031-06-13
Drug substance claim: No
Drug product claim: Yes
Assignee: Galderma Research and Development SNC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.